Skip to main content

Table 5 Predicted utilities from 3 scenarios

From: Comparing the mapping between EQ-5D-5L, EQ-5D-3L and the EORTC-QLQ-C30 in non-small cell lung cancer patients

 

Possible QLQ-C30 Score

Predicted

Model

Function

Symptom

EQ-5D-3L

EQ-5D-5L

Random effects

Best (100)

Best (0)

0.89

0.96

 

Worst (0)

Worst (100)

0.10

0.019

Beta Binomial

Best (100)

Best (0)

0.901

0.983

 

Worst (0)

Worst (100)

0.097

0.0094

LDVMM

Best (100)

Best (0)

0.884

0.972

 

Worst (0)

Worst (100)

0.055

0.008